What do conservative talk show host Rush Limbaugh, singer Courtney Love and deceased actor Heath Ledger all have in common? The answer, according to published reports, is that all battled addiction to OxyContin
Quick Read
Physician Group Calls On Government To Rein In Drug PricesMarch 29, 2016 |
It’s not just patients who are getting tired of ever-rising drug prices. Doctors are joining the chorus of frustration. The latest voice? The American College of Physicians, whose membership includes 143,000 internal medicine doctors, published a position paper Monday calling for the government and industry to take steps to rein in spiraling costs
Quick Read
A Massachusetts Institute of Technology economist and Harvard oncologist have a proposal to get highly effective but prohibitively expensive drugs into consumers’ hands: health care installment loans
Quick Read
Now There’s ProofMarch 17, 2016 |
The more money doctors receive from drug and medical device companies, the more brand-name drugs they tend to prescribe, a new ProPublica analysis shows. Even a meal can make a difference
Quick Read
Why Some Prisons are Spending Millions on a Pricey New DrugFebruary 23, 2016 |
Corrections facilities are ground zero for treating hepatitis C — but at a cost
Quick Read
Obama Introduces Evidence Generation Strategy to Reduce High Drug CostsFebruary 18, 2016 |
The budget included a number of surprising, new proposals that underscore how post-market evidence might play an increasing role in controlling drug prices in coming years
Quick Read
Lawsuits Claim Insurers Unfairly Refuse Pricey Hepatitis C DrugsFebruary 3, 2016 |
Two Washington state insurers — Group Health Cooperative and BridgeSpan — are targeted in class-action lawsuits that claim the companies are unfairly rationing new drugs that can cure hepatitis C based on high cost, not medical need
Quick Read
Drug Makers Dismiss Outrage Over High Prices As ‘Abomination’January 13, 2016 |
Public anger at drug companies is “an abomination,” Ron Cohen, chairman of the big industry group BIO, said at the Biotech Showcase. All the talk about pharma profiteering, Cohen said, is “a perversion of reality.”
Quick Read